Clinical and Prognostic Significance of PD-L1, Beclin 1 and Fascin 1 Immunohistochemical Expression in Colorectal Carcinoma by Sabah Mohamed Hanafy, Heba Mohammed Rashad, Adel Bakry, Asmaa A Mahmoud, Mahmoud Abdou Yassin, Mostafa M Elaidy, Mai M Abdelwahab

Subjects: Get full text

Successful Treatment of Pulmonary Pleomorphic Carcinoma with Nivolumab: A Case Report by Eriko Fujimoto, Takashi Yokoi, Koji Mikami, Shingo Kanemura, Eisuke Shibata, Daisuke Horio, Yuichi Koda, Yoshiki Negi, Yumiko Akano, Akio Tada, Toshiyuki Minami, Kozo Kuribayashi, Takashi Kijima

Subjects: Get full text

Interobserver Reproducibility of PD-L1 Biomarker in Non-small Cell Lung Cancer: A Multi-Institutional Study by 27 Pathologists by Sunhee Chang, Hyung Kyu Park, Yoon-La Choi, Se Jin Jang

Subjects: “…programmed cell death-ligand 1…”
Get full text

PD-L1 expression and the prognostic significance in gastric cancer: a retrospective comparison of three PD-L1 antibody clones (SP142, 28–8 and E1L3N) by Jing Ma, Jianhui Li, Meirui Qian, Weili Han, Miaomiao Tian, Zengshan Li, Zhe Wang, Shuixiang He, Kaichun Wu

Subjects: “…Programmed cell death ligand 1…”
Get full text

PD-L1 expression in invasive solid papillary breast carcinomas by Sevdegul Aydın Mungan, Zeynep Sagnak Yılmaz, Ismail Saygın, Emel Cakır, Safak Ersoz, Umit Cobanoglu

Subjects: Get full text

Biomarkers for Predicting Response to Personalized Immunotherapy in Gastric Cancer by Moonsik Kim, Ji Yun Jeong, An Na Seo

Subjects: Get full text

Assessment of programmed cell death 1 and its programmed cell death ligand 1 levels in vitiligo by Hanan R. Nada, Ahmed Mourad, Laila A. Rashed, Ghada M. El-Hanafy, Nermeen M.A. Abdallah, Mohamed M. Abdelhady

Subjects: Get full text

Expression of PDL-1 Receptors in Prostate Cancer Patients and its Association with Tumour Aggressiveness: A Cross-sectional Study by Gaurav Gupta, Sumit Gahlawat, Hemant Goel, Ravi Kant Singh, Karandeep Guleria, Rajeev Sood

Subjects: Get full text

Brain Metastases Status and Immunotherapy Efficacy in Advanced Lung Cancer: A Systematic Review and Meta-Analysis by Hao Hu, Zhi-Yong Xu, Qian Zhu, Xi Liu, Si-Cong Jiang, Ji-Hua Zheng

Subjects: Get full text

Lower neutrophil‐to‐lymphocyte ratio and positive programmed cell death ligand‐1 expression are favorable prognostic markers in patients treated with pembrolizumab for urothelial c... by Yu Miyama, Go Kaneko, Koshiro Nishimoto, Masanori Yasuda

Subjects: Get full text

Clinicopathologic Significance and Prognostic Value of Programmed Cell Death Ligand 1 (PD-L1) in Patients With Hepatocellular Carcinoma: A Meta-Analysis by Jing-Hua Li, Wei-Jie Ma, Gang-Gang Wang, Xiang Jiang, Xi Chen, Long Wu, Zhi-Su Liu, Xian-Tao Zeng, Fu-Ling Zhou, Yu-Feng Yuan

Subjects: “…programmed cell death ligand-1…”
Get full text

Clinicopathological and prognostic value of PD-L1 in urothelial carcinoma: a meta-analysis by Ding X, Chen Q, Yang Z, Li J, Zhan H, Lu N, Chen M, Yang Y, Wang J, Yang D

Subjects: Get full text

Lanosterol synthase deficiency promotes tumor progression by orchestrating PDL1‐dependent tumor immunosuppressive microenvironment by Yuan Gao, Kun Zhao, Yulan Huang, Dapeng Zhang, Na Luo, Xiaoqing Peng, Feng Yang, Weidong Xiao, Meng Wang, Rongchen Shi, Hongming Miao

Subjects: Get full text

PD-L1 Expression Correlated with Clinicopathological Factors and Akt/Stat3 Pathway in Oral SCC by Dong-Ho Geum, Dae-Seok Hwang, Chang-Hun Lee, Sung-Dae Cho, Min-A Jang, Mi-Heon Ryu, Uk-Kyu Kim

Subjects: “…programmed cell death ligand 1…”
Get full text

CD45RO+ Memory T Lymphocytes As A Candidate Marker for Non–small Cell Lung Cancer by Qifan TAN, Haoyang LI, Mengjun YU, Xiaonan TANG, Jinjing TAN, Shucai ZHANG, Jinghui WANG

Subjects: Get full text

Prediction of PD-L1 and Ki-67 status in primary central nervous system diffuse large B-cell lymphoma by diffusion and perfusion MRI: a preliminary study by Xiaofang Zhou, Feng Wang, Lan Yu, Feiman Yang, Jie Kang, Dairong Cao, Zhen Xing

Subjects: Get full text

Comparative Study of PD-L1 Expression in Different Sites of 
Non-small Cell Lung Cancer by Xiaozheng HUANG, Jianghua WU, Lixin ZHOU, Zhijie SONG, Wantong XU, Ling JIA, Xinting DIAO, Qi WU, Dongmei LIN

Subjects: Get full text

Programmed Cell Death-Ligand 1 Expression Status in Urothelial Carcinoma According to Clinical and Pathological Factors: A Multi-Institutional Retrospective Study by Hyung Suk Kim, Won Sik Jang, Won Sik Ham, Seung Il Jung, Dong Hyun Lee, Ja Hyeon Ku, Hong Koo Ha, Ja Yoon Ku, Se Young Choi, In Ho Chang, Taesoo Choi, Wan Song, Seong Soo Jeon, Byong Chang Jeong, Sung Han Kim, Ho Kyung Seo

Subjects: Get full text

Elevated serum soluble programmed cell death ligand 1 concentration as a potential marker for poor prognosis in small cell lung cancer patients with chemotherapy by Jianjun Jin, Jiming Si, Yuanhua Liu, Huanqin Wang, Ran Ni, Jing Wang

Subjects: Get full text

Efficacy of immune checkpoint inhibitors according to PD‐L1 tumor proportion scores in non‐small cell lung cancer by Seongho Park, Yoo‐Duk Choi, Jieun Kim, Bo‐Gun Kho, Cheol‐Kyu Park, In‐Jae Oh, Young‐Chul Kim

Subjects: Get full text